✦ LIBER ✦

Current Approaches in the Treatment of Parkinson's Disease

✍ Scribed by Stacy, M; Jankovic, J

Book ID: 118145081
Publisher: Annual Reviews
Year: 1993
Tongue: English
Weight: 493 KB
Volume: 44
Category: Article
ISSN: 0066-4219
DOI: 10.1146/annurev.me.44.020193.002243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current strategies in the treatment of P

Current strategies in the treatment of Parkinson’s disease and a personalized approach to management

✍ Diaz, Nancy L; Waters, Cheryl H 📂 Article 📅 2009 🏛 Expert Reviews 🌐 English ⚖ 244 KB

Current approaches to management of depr

Current approaches to management of depression in Parkinson’s Disease

✍ F.J.E. Vajda; C. Solinas 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Current approaches in the treatment of A

Current approaches in the treatment of Alzheimer's disease

✍ Reena S. Shah; Hyoung-Gon Lee; Zhu Xiongwei; George Perry; Mark A. Smith; Rudy J 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Current Pharmacotherapeutic Treatment Op

Current Pharmacotherapeutic Treatment Options in Parkinson’s Disease

✍ Michael Rezak 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 1 views

## Abstract The original article to which this Erratum refers was published in the September, 2004 issue of __Movement__ Disorders (2004) 19 (9) 997–1005.

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

✍ C. Warren Olanow; Yves Agid; Yoshi Mizuno; Alberto Albanese; U. Bonucelli; Phili 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract Levodopa is the most effective symptomatic agent in the treatment of Parkinson's disease (PD) and the “gold standard” against which new agents must be compared. However, there remain two areas of controversy: (1) whether levodopa is toxic, and (2) whether levodopa directly causes motor